Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab
Andrew B. Nixon,Yingmiao Liu,Qian Yang,Bin Luo,Mark D. Starr,John C. Brady,Wm. Kevin Kelly,Himisha Beltran,Michael J. Morris,Daniel J. George,Andrew J. Armstrong,Susan Halabi